Individual patient data meta-analysis of trial of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: Protocol for a systematic review

被引:5
|
作者
Farmer, A. J. [1 ]
Heneghan, C. [1 ]
Barnett, A. H. [2 ,3 ]
Davidson, M. B. [4 ]
Guerci, B. [5 ,6 ]
O'Kane, M. [7 ]
Schwedes, U. [8 ]
Perera, R. [1 ]
机构
[1] Univ Oxford, NIHR Sch Primary Care Res, Dept Primary Hlth Care, Oxford, England
[2] Univ Birmingham, Dept Med, Birmingham, W Midlands, England
[3] Birmingham Heartlands Hosp, Heart England Natl Hlth Serv Fdn Trust, Birmingham, W Midlands, England
[4] Charles Drew Univ, Clin Ctr Res Excellence, Los Angeles, CA USA
[5] Univ Nancy, Diabetol,Metab Dis & Nutrit, BP 90303, F-54201 Toul, France
[6] CHU, Hosp Jeanne Arc, CIC Inserm, BP 90303, F-54201 Toul, France
[7] Altnagelvin Hosp, Dept Clin Chem, Western Hlth & Social Care Trust, Londonderry, Ireland
[8] Diabet Zentrum Hamburg City, Monckebergstr 5, D-20095 Hamburg, Germany
关键词
Study protocol; Individual patient data; meta-analysis; Self-monitoring of blood glucose; Type; 2; diabetes; PARALLEL-GROUP; MANAGEMENT; MELLITUS; EFFICACY;
D O I
10.1016/j.pcd.2009.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim of the study: Recent trials have provided differing estimates of the benefits of self-monitoring of blood glucose (SMBG) for non-insulin treated patients with type 2 diabetes. Designing and conducting randomised trials to demonstrate the efficacy of complex interventions is challenging. Variations in the components of the intervention delivered, target population selected, and reporting methods used have limited the conclusions drawn in recent systematic reviews. We will systematically examine these factors within the trials of SMBG to enable further investigation of the data through an individual patient data analysis (IPD). Methods/design: The IPD analysis will include data from randomised trials comparing blood glucose self-monitoring and decisions about self-management versus a control group with standardised or routine care. The data requested for each trial will include outcomes (HbA1c, blood glucose and quality of life), potential moderators of effect (e.g. demographic variables, clinical data and psychosocial factors) and intervention descriptors. The primary outcome of interest will be HbA1c. Secondary outcomes include alternative measures of glycaemia, cardiovascular risk factors, persistence with monitoring, and measures of health status, quality of life and psychosocial factors. Analysis of patient sub-groups defined by age at randomisation, gender, prior use of monitoring and health status will be carried out. An intention to treat analysis will be performed and assessed for clinical and statistical heterogeneity. With current uncertainty about the extent of benefit from SMBG for non-insulin treated patients with type 2 diabetes, this study will provide the best estimates to date of overall effectiveness, effectiveness within potential target populations, and optimal components of the intervention. (C) 2009 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:117 / 121
页数:5
相关论文
共 50 条
  • [1] Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis
    Allemann, Sabin
    Houriet, Carine
    Diem, Peter
    Stettler, Christoph
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) : 2903 - 2913
  • [2] Individual patient data meta-analysis of trials of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: Protocol for a systematic review (vol 3, pg 117, 2009)
    Farmer, A. J.
    Heneghan, C.
    Barnet, A. H.
    Davidson, M. B.
    Guerci, B.
    O'Kane, M.
    Schwedes, U.
    Perera, R.
    PRIMARY CARE DIABETES, 2011, 5 (02) : 143 - 143
  • [3] Meta-Analysis of Individual Participant Data in Randomized Trials of Self-Monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes Patients
    Farmer, Andrew J.
    Perera, Rafael
    Ward, Alison
    Heneghan, Carl
    Oke, Jason
    Barnett, Anthony H.
    Davidson, Mayer B.
    Guerci, Bruno
    O'Kane, Maurice
    Schwedes, Ulrich
    O'Malley, Simon
    DIABETES, 2011, 60 : A236 - A236
  • [4] Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes
    Farmer, Andrew J.
    Perera, Rafael
    Ward, Alison
    Heneghan, Carl
    Oke, Jason
    Barnett, Anthony H.
    Davidson, Mayer B.
    Guerci, Bruno
    Coates, Vivien
    Schwedes, Ulrich
    O'Malley, Simon
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [5] Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial
    Parsons, Sharon
    Luzio, Stephen
    Bain, Stephen
    Harvey, John
    McKenna, Jillian
    Khan, Atir
    Rice, Sam
    Watkins, Alan
    Owens, David R.
    BMC ENDOCRINE DISORDERS, 2017, 17
  • [6] Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial
    Sharon Parsons
    Stephen Luzio
    Stephen Bain
    John Harvey
    Jillian McKenna
    Atir Khan
    Sam Rice
    Alan Watkins
    David R. Owens
    BMC Endocrine Disorders, 17
  • [7] The SMBG study: a randomised controlled trial of self-monitoring of blood glucose in non-insulin treated type 2 diabetes
    Parsons, S. N.
    Luzio, S. D.
    Owens, D. R.
    DIABETOLOGIA, 2017, 60 : S302 - S303
  • [8] Blood glucose self-monitoring in diabetes control in non-insulin treated type 2 diabetic patients
    Schwedes, U
    Siebolds, M
    Mertes, G
    DIABETOLOGIA, 2001, 44 : A229 - A229
  • [9] Examining the evidence for self-monitoring of blood glucose in non-insulin Type 2 diabetes
    Kirk, Julienne K.
    Namak, Shahla
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (01) : 1 - 4
  • [10] Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis
    Tucker, Katherine L.
    Sheppard, James P.
    Stevens, Richard
    Bosworth, Hayden B.
    Bove, Alfred
    Bray, Emma P.
    Earley, Kenneth
    George, Johnson
    Godwin, Marshall
    Greee, Beverly B.
    Hebert, Paul
    Hobbs, F. D. Richard
    Kantola, Ilkka
    Kerry, Sally M.
    Leiva, Alfonso
    Magid, David J.
    Mant, Jonathan
    Margolis, Karen L.
    McKinstry, Brian
    McLaughlin, Mary Ann
    Omboni, Stefano
    Ogedegbe, Olugbenga
    Parati, Gianfranco
    Qamar, Nashat
    Tabaei, Bahman P.
    Varis, Juha
    Verberk, Willem J.
    Wakefield, Bonnie J.
    McManus, Richard J.
    PLOS MEDICINE, 2017, 14 (09)